Registered number
NI658296
Eolas Medical Limited
Unaudited Filleted Accounts
31 January 2025
Eolas Medical Limited
Registered number: NI658296
Balance Sheet
as at 31 January 2025
Notes 2025 2024
£ £
Fixed assets
Tangible assets 3 27,787 31,047
Investments 4 1,206,025 -
1,233,812 31,047
Current assets
Debtors 5 308,350 170,630
Cash at bank and in hand 617,765 2,591,744
926,115 2,762,374
Creditors: amounts falling due within one year 6 (498,947) (23,396)
Net current assets 427,168 2,738,978
Total assets less current liabilities 1,660,980 2,770,025
Creditors: amounts falling due after more than one year 7 (1,200,000) -
Net assets 460,980 2,770,025
Capital and reserves
Called up share capital 20 20
Share premium 7,245,629 6,736,810
Profit and loss account (6,784,669) (3,966,805)
Shareholders' funds 460,980 2,770,025
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Declan Kelly
Director
Approved by the board on 14 May 2025
Eolas Medical Limited
Notes to the Accounts
for the year ended 31 January 2025
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the rendering of services. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Intangible fixed assets
Intangible fixed assets are measured at cost less accumulative amortisation and any accumulative impairment losses.
Tangible fixed assets
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
Freehold buildings over 50 years
Leasehold land and buildings over the lease term
Plant and machinery over 5 years
Fixtures, fittings, tools and equipment over 5 years
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Provisions
Provisions (ie liabilities of uncertain timing or amount) are recognised when there is an obligation at the reporting date as a result of a past event, it is probable that economic benefit will be transferred to settle the obligation and the amount of the obligation can be estimated reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Pensions
Contributions to defined contribution plans are expensed in the period to which they relate.
2 Employees 2025 2024
Number Number
Average number of persons employed by the company 12 17
3 Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 February 2024 50,057
Additions 7,425
At 31 January 2025 57,482
Depreciation
At 1 February 2024 19,010
Charge for the year 10,685
At 31 January 2025 29,695
Net book value
At 31 January 2025 27,787
At 31 January 2024 31,047
4 Investments
Investments in
subsidiary
undertakings
£
Cost
Additions 1,206,025
At 31 January 2025 1,206,025
5 Debtors 2025 2024
£ £
Trade debtors 161,527 -
Other debtors 146,823 170,630
308,350 170,630
6 Creditors: amounts falling due within one year 2025 2024
£ £
Trade creditors 11,842 -
Taxation and social security costs 75,339 18,639
Other creditors 411,766 4,757
498,947 23,396
7 Creditors: amounts falling due after one year 2025 2024
£ £
Other creditors 1,200,000 -
8 Share-based payment
During the year the company issued employee share option agreements. These options vest over four years from the date of employment, in equal monthly tranches during years 2-4, and will lapse after ten years from grant date. 6,400 (2023: 5,895) share options vested during the period. A total of 7,193 share options were exercisable at the end of the period. The fair value of these options was measured using the value of the latest transaction in the share capital of the company, and the total expense recognised in the profit and loss account is £508,819 (2024: £527,999).
9 Events after the reporting date
After the balance sheet date but before the accounts were signed, vested share options which are accounted for on the balance sheet totalling £571,835, granted to employees and exercisable at period end, have lapsed. The employees chose not to exercise these options within the contractually defined window and are now deemed to be lapsed. This is a non-adjusting event in accordance with the relevant accounting standards and as such no adjustments have been made to the accounts.
10 Contingent liabilities
A contingent liability exists to repay government grants should certain conditions under which they were awarded, as stated in the Letter of Offer, cease to be met.
11 Related party transactions
The Key Management Personnel received total remuneration of £80,683 (2024: £77,250).
12 Other information
Eolas Medical Limited is a private company limited by shares and incorporated in Northern Ireland. Its registered office is:
26 Greenwood Hill
Belfast
Northern Ireland
BT8 7WF
Eolas Medical Limited NI658296 false 2024-02-01 2025-01-31 2025-01-31 VT Final Accounts April 2024 Declan Kelly No description of principal activity NI658296 2023-02-01 2024-01-31 NI658296 core:WithinOneYear 2024-01-31 NI658296 core:AfterOneYear 2024-01-31 NI658296 core:ShareCapital 2024-01-31 NI658296 core:SharePremium 2024-01-31 NI658296 core:RetainedEarningsAccumulatedLosses 2024-01-31 NI658296 2024-02-01 2025-01-31 NI658296 bus:PrivateLimitedCompanyLtd 2024-02-01 2025-01-31 NI658296 bus:AuditExemptWithAccountantsReport 2024-02-01 2025-01-31 NI658296 bus:Director40 2024-02-01 2025-01-31 NI658296 1 2024-02-01 2025-01-31 NI658296 2 2024-02-01 2025-01-31 NI658296 core:PlantMachinery 2024-02-01 2025-01-31 NI658296 1 2024-02-01 2025-01-31 NI658296 countries:England 2024-02-01 2025-01-31 NI658296 bus:FRS102 2024-02-01 2025-01-31 NI658296 bus:FilletedAccounts 2024-02-01 2025-01-31 NI658296 2025-01-31 NI658296 core:WithinOneYear 2025-01-31 NI658296 core:AfterOneYear 2025-01-31 NI658296 core:ShareCapital 2025-01-31 NI658296 core:SharePremium 2025-01-31 NI658296 core:RetainedEarningsAccumulatedLosses 2025-01-31 NI658296 core:PlantMachinery 2025-01-31 NI658296 core:AdditionsToInvestments 2025-01-31 NI658296 2024-01-31 NI658296 core:PlantMachinery 2024-01-31 iso4217:GBP xbrli:pure